ArticleClinical medicine (London, England)2021
COVID-19 in pregnancy.
Article in Clinical medicine (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 44 citations in OpenAlex.
- Treatment and Outcomes of COVID-19 Infection in Pregnant Women: Systematic Review of Cases Reported in Europe.Journal of clinical medicine · 2025Review
- Impact of Omicron BA.5 infection on maternal and neonatal outcomes.Frontiers in cellular and infection microbiology · 2025Article
- COVID-19 vaccine barriers among pregnant and lactating refugee women: a case study.Frontiers in public health · 2025Article
- Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan.Human vaccines & immunotherapeutics · 2024Article
- Article
- The Psychological Impact on Romanian Women Infected with SARS-CoV-2 during Pregnancy.Healthcare (Basel, Switzerland) · 2024Article
- COVID-19 in pregnancy: A cross-sectional study on clinical features, disease severity, and health outcome.Biomolecules & biomedicine · 2024Article
- Strategies to Improve COVID-19 Vaccination in a Pregnant, Marginalized Population: Quality Improvement Project.American journal of public health · 2024Article
- Pregnant Patients with COVID-19 Admitted to an ICU: A Comparison with a Historical Cohort of Critical Pregnant Patients without COVID-19.Life (Basel, Switzerland) · 2024Article
- Assessing the Impact of COVID-19 Vaccination on Preterm Birth: A Systematic Review with Meta-Analysis.Vaccines · 2024Review
- Physical development of infants born to patients with COVID-19 during pregnancy: 2 years of age.PeerJ · 2024Observational
- Risk Factors for Severe-Critical COVID-19 in Pregnant Women.Journal of clinical medicine · 2023Article
- Critical respiratory failure due to pregnancy complicated by COVID-19 and bacterial coinfection: A case report.World journal of clinical cases · 2023Article
- Use of Sotrovimab in a cohort of pregnant women with a high risk of COVID 19 progression: a single-center experience.Pathogens and global health · 2023Article
- Assessment of the scope, completeness, and consistency of various drug information resources related to COVID-19 medications in pregnancy and lactation.BMC pregnancy and childbirth · 2023Article
- The course of infection with the Delta variant of COVID-19 in pregnancy: analysis of clinical, laboratory, and neonatal outcomesJournal of the Turkish German Gynecological Association · 2023Article
- A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal-fetal interface.Frontiers in immunology · 2023Article
- The Entero-Mammary Pathway and Perinatal Transmission of Gut Microbiota and SARS-CoV-2.International journal of molecular sciences · 2022Article
- Decreased fetal cardiac output in pregnant women with severe SARS-Cov-2 infection.Echocardiography (Mount Kisco, N.Y.) · 2022Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pregnant women with COVID-19 are less likely to be symptomatic than non-pregnant counterparts. Risk factors for severe disease include being overweight or obese, greater than 35 years old, and having pre-existing comorbidities. Those who develop severe disease have increased rates of admission to an intensive care unit, requiring invasive ventilation and pre-term birth.Pregnant and breastfeeding women with COVID-19 should be investigated as of outside pregnancy and should receive proven therapies (such as corticosteroids and tocilizumab) on a risk/benefit basis. Admitted women should receive multidisciplinary care with input from senior decision makers and early escalation where required. There are no safety concerns -surrounding the COVID-19 vaccination and fertility or pregnancy, and so it should be offered to women based on their age and clinical risk group, in line with non-pregnant women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.